OncoMatch/Clinical Trials/NCT07033026
An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.
Is NCT07033026 recruiting? Yes, currently enrolling (Jun 2026). This Phase 2 trial studies multiple treatments including NGM120 Q4W and NGM120 Q8W for colorectal cancer.
Treatment: NGM120 Q4W · NGM120 Q8W — A multi-center evaluation of NGM120 in a randomized, double-blind, placebo-controlled study in participants with colorectal cancer who have cancer cachexia.
Check if I qualifyExtracted eligibility criteria
Treatments studied
Other
Cancer type
Colorectal Cancer
Structured fields extracted by AI. May contain errors — verify against the official protocol.
US trial sites
- NGM Clinical Study Site · Laredo, Texas
Showing up to 5 US sites.
See all sites on ClinicalTrials.gov →Frequently asked questions
Is NCT07033026 currently recruiting?
Yes, this trial is currently recruiting patients.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualifyRelated pages